GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OTCPK:CLPBF) » Definitions » Cyclically Adjusted PS Ratio

Coloplast A/S (Coloplast A/S) Cyclically Adjusted PS Ratio : 8.56 (As of Apr. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Coloplast A/S's current share price is $119.50. Coloplast A/S's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $13.96. Coloplast A/S's Cyclically Adjusted PS Ratio for today is 8.56.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted PS Ratio or its related term are showing as below:

CLPBF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.55   Med: 11.06   Max: 16.78
Current: 9.72

During the past years, Coloplast A/S's highest Cyclically Adjusted PS Ratio was 16.78. The lowest was 7.55. And the median was 11.06.

CLPBF's Cyclically Adjusted PS Ratio is ranked worse than
86.45% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs CLPBF: 9.72

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Coloplast A/S's adjusted revenue per share data for the three months ended in Dec. 2023 was $4.423. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $13.96 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PS Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.75 14.58 13.55 8.96 8.09

Coloplast A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.27 10.03 9.43 8.09 8.28

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PS Ratio falls into.



Coloplast A/S Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Coloplast A/S's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=119.50/13.96
=8.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Coloplast A/S's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=4.423/116.7000*116.7000
=4.423

Current CPI (Dec. 2023) = 116.7000.

Coloplast A/S Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 2.649 99.600 3.104
201406 2.675 99.700 3.131
201409 2.636 99.700 3.085
201412 2.567 99.400 3.014
201503 2.343 100.200 2.729
201506 2.494 100.300 2.902
201509 2.575 100.200 2.999
201512 2.503 99.800 2.927
201603 2.529 100.200 2.945
201606 2.618 100.600 3.037
201609 2.660 100.200 3.098
201612 2.510 100.300 2.920
201703 2.625 101.200 3.027
201706 2.783 101.200 3.209
201709 2.989 101.800 3.426
201712 2.957 101.300 3.407
201803 3.148 101.700 3.612
201806 3.123 102.300 3.563
201809 3.118 102.400 3.553
201812 3.098 102.100 3.541
201903 3.119 102.900 3.537
201906 3.269 102.900 3.707
201909 3.193 102.900 3.621
201912 3.286 102.900 3.727
202003 3.354 103.300 3.789
202006 3.126 103.200 3.535
202009 3.412 103.500 3.847
202012 3.643 103.400 4.112
202103 3.568 104.300 3.992
202106 3.673 105.000 4.082
202109 3.785 105.800 4.175
202112 3.683 106.600 4.032
202203 3.825 109.900 4.062
202206 3.906 113.600 4.013
202209 3.798 116.400 3.808
202212 4.093 115.900 4.121
202303 4.105 117.300 4.084
202306 4.179 116.400 4.190
202309 3.965 117.400 3.941
202312 4.423 116.700 4.423

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (OTCPK:CLPBF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Coloplast A/S Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (Coloplast A/S) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (Coloplast A/S) Headlines

From GuruFocus

Coloplast A/S's Dividend Analysis

By GuruFocus Research 12-07-2023